Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Rothman

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Vaccine|July 1, 2015
Trials and tribulations on the path to developing a dengue vaccineStephen J Thomas, Alan L Rothman
Viral Immunology|May 14, 2009
Cross-reactive memory CD4+ T cells alter the CD8+ T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific mannerCoreen M Beaumier, Alan L Rothman
Archives of Pathology & Laboratory Medicine|October 21, 2016
Zika Virus: The Agent and Its Biology, With Relevance to PathologyCarey L Medin, Alan L Rothman
Nature Medicine|July 2, 2003
Dengue immune response: low affinity, high febrilityRaymond M Welsh, Alan L Rothman
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypesMaloy M Mangada, Alan L Rothman
The Journal of Infectious Diseases|February 25, 2016
Dengue Vaccine: The Need, the Challenges, and ProgressAlan L Rothman, Francis A Ennis
Mbio|August 10, 2021
Viral Suppression of RIPK1-Mediated SignalingDarshika J Udawatte, Alan L Rothman
American Journal of Preventive Medicine|November 23, 2015
Trials and Tribulations on the Path to Developing a Dengue VaccineStephen J Thomas, Alan L Rothman
Tropical Medicine & International Health : TM & IH|September 23, 2008
Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populationsJames A Potts, Alan L Rothman
The Journal of Infectious Diseases|March 18, 2006
Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatmentCarey L Medin, Alan L Rothman
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Vaccine|July 1, 2015
Trials and tribulations on the path to developing a dengue vaccineStephen J Thomas, Alan L Rothman
Viral Immunology|May 14, 2009
Cross-reactive memory CD4+ T cells alter the CD8+ T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific mannerCoreen M Beaumier, Alan L Rothman
Archives of Pathology & Laboratory Medicine|October 21, 2016
Zika Virus: The Agent and Its Biology, With Relevance to PathologyCarey L Medin, Alan L Rothman
Nature Medicine|July 2, 2003
Dengue immune response: low affinity, high febrilityRaymond M Welsh, Alan L Rothman
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypesMaloy M Mangada, Alan L Rothman
The Journal of Infectious Diseases|February 25, 2016
Dengue Vaccine: The Need, the Challenges, and ProgressAlan L Rothman, Francis A Ennis
Mbio|August 10, 2021
Viral Suppression of RIPK1-Mediated SignalingDarshika J Udawatte, Alan L Rothman
American Journal of Preventive Medicine|November 23, 2015
Trials and Tribulations on the Path to Developing a Dengue VaccineStephen J Thomas, Alan L Rothman
Tropical Medicine & International Health : TM & IH|September 23, 2008
Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populationsJames A Potts, Alan L Rothman
The Journal of Infectious Diseases|March 18, 2006
Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatmentCarey L Medin, Alan L Rothman
Pageof 17